Pineoblastomas, which originate from the pineal gland, are extremely malignant tumors that grow quickly and aggressively. Because they spread so fast and the probability of longterm survival is poor, it is important to diagnose these tumors early. This article discusses magnetic resonance's role in imaging pineoblastomas. MR is particularly effective for this task due to its ability to visualize the pineoblastoma in three different planes, both before and after the administration of gadolinium.

Download full-text PDF

Source

Publication Analysis

Top Keywords

imaging pineoblastomas
8
pineoblastomas pineoblastomas
4
pineoblastomas originate
4
originate pineal
4
pineal gland
4
gland extremely
4
extremely malignant
4
malignant tumors
4
tumors grow
4
grow aggressively
4

Similar Publications

[A case of synchronous mediastinal and pineal germ cell tumors].

Zhonghua Er Ke Za Zhi

January 2025

Department of Medical Oncology, Pediatric Oncology Center,Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, National Key Clinical Discipline of Pediatric Oncology,Laboratory for Clinical Medicine, Capital Medical University, Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing100045, China.

View Article and Find Full Text PDF
Article Synopsis
  • * These tumors often cause obstructive hydrocephalus and symptoms such as headaches, nausea, and impaired gait due to mass effect.
  • * Diagnosis primarily relies on imaging, while biopsy is required for histologic confirmation, except for germinomas, which can be identified through specific tumor markers; treatments vary from surgery for benign tumors to additional chemotherapy and radiotherapy for malignant ones.
View Article and Find Full Text PDF

Pineal parenchymal tumors are rare neoplasms for which evidence-based treatment recommendations are lacking. These tumors vary in biology, clinical characteristics, and prognosis, requiring treatment that ranges from surgical resection alone to intensive multimodal antineoplastic therapy. Recently, international collaborative studies have shed light on the genomic landscape of these tumors, leading to refinement in molecular-based disease classification in the 5th edition of the World Health Organization (WHO) classification of tumors of the central nervous system.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!